Polio eradication 'at risk' as Chad and Pakistan face continued outbreaks, GPEI report says

NewsGuard 100/100 Score

"According to the latest report from the Independent Monitoring Board (IMB) of the Global Polio Eradication Initiative (GPEI), continued transmission of polio is a 'global health emergency,' and plans to interrupt transmission by the end of 2012 are 'at risk,'" the Lancet Infectious Diseases reports, adding, "With a US$590 million funding gap and weak political leadership in some countries, the engagement of communities to plan and implement local approaches is paramount."

"Notable progress has been made in India and Afghanistan, but the situation in Chad is 'particularly alarming,' says the IMB, while 'Pakistan risks becoming the last global outpost of this vicious disease,'" the journal writes (Morris, September 2011). According to IRIN, "Pakistan has seen a rising number of polio cases since 2007, with 69 reported so far this year as against 37 in the same period of 2010." The article says insecurity is a major cause because it hinders the movement of vaccination teams (8/22).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New RNA therapy zilebesiran shows promise in lowering blood pressure